- Clinical Pharmacology
- Next »
Parnate
Clinical Pharmacology
CLINICAL PHARMACOLOGY
Parnate
Action
Tranylcypromine is a non-hydrazine monoamine oxidase inhibitor with a rapid onset of activity. It increases the concentration of epinephrine, norepinephrine, and serotonin in storage sites throughout the nervous system and, in theory, this increased concentration of monoamines in the brain stem is the basis for its antidepressant activity. When tranylcypromine is withdrawn, monoamine oxidase activity is recovered in 3 to 5 days, although the drug is excreted in 24 hours.
- Clinical Pharmacology
- Next »
WebMD Resources
Antidepressant Side Effects
A new study says over half of all people treated with antidepressants stop taking them because of side effects. See more WebMD Videos »
Emotional Wellness
Get tips on therapy and treatment.


